Evacetrapib (LY2484595)

Evacetrapib (LY2484595) is a potent and selective inhibitor of CETP with IC50 of 5.5 nM, elevates HDL cholesterol without increases in aldosterone or blood pressure. Phase 3.

Price Not Available 5mg Evacetrapib (LY2484595) Supplier Page

Trivial name	N/A
Catalog Number	S2925
Molecular Formula	C31H36F6N6O2
CAS#	1186486-62-3
Inchi	InChI=1S/C31H36F6N6O2/c1-18-11-19(2)27-25(12-18)26(5-4-10-42(27)16-20-6-8-22(9-7-20)28(44)45)43(29-38-40-41(3)39-29)17-21-13-23(30(32,33)34)15-24(14-21)31(35,36)37/h11-15,20,22,26H,4-10,16-17H2,1-3H3, (H,44,45)/t20-,22-,26-/m0/s1
Inchi Key	IHIUGIVXARLYHP-YBXDKENTSA-N
SMILES	CC1=CC(=C2C(=C1)C(CCCN2CC3CCC(CC3)C(=O)O)N(CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=NN(N=N5)C)C
Size	5mg
Supplier Page	http://www.selleckchem.com/products/evacetrapib-ly2484595.html
Additional Information	https://file.selleck.cn/downloads/struct/Evacetrapib-LY-2484595-chemical-structure-s2925.jpg